Who is this course for?
Clinicians, including MDs, DOs, NPs, and CRNAs
Intensive ketamine infusion training for clinicians, presented as a Mini-Fellowship and focused on evidence-based didactics, supervised clinical experience, and individual experiential training. The program is described as meeting or exceeding APA and ASA recommendations for didactic and supervised clinical training.
Ketamine Research Institute
English
6 weeks
The Ketamine Research Institute Training Program offers a "Mini-Fellowship" to equip clinicians with advanced, evidence-based knowledge and hands-on experience in ketamine infusion therapy. The program adheres to the highest standards, meeting or exceeding all American Psychiatric Association (APA) and American Society of Anesthesiologists (ASA) training recommendations. It covers a Precision Medicine-based approach and Target-Controlled Infusion methodology, aiming to elevate the standard of care in ketamine therapy for mood disorders. The course encompasses evidence-based didactics, supervised clinical experience, and individual experiential training, ensuring that clinicians are well-prepared to administer this complex yet promising treatment safely and effectively.
This training is particularly timely given the rising demand for alternative treatments for mood disorders and chronic pain conditions. The program addresses the need for specialized training in the administration of ketamine, emphasizing the importance of adhering to safe and uniform infusion protocols. By completing this intensive training, clinicians will be at the forefront of a revolutionary approach to mental health treatment, equipped with the skills and knowledge to offer ketamine therapy as a safe and effective treatment option for their patients.
Clinicians, including MDs, DOs, NPs, and CRNAs
MD, DO, NP, or CRNA
The Ketamine Research Institute is a US-based clinical research organization developing precision medicine approaches to ketamine infusion therapy, studying optimized dosing protocols to treat depression and offering clinician training in evidence-based ketamine practice.
Clinicians, including MDs, DOs, NPs, and CRNAs
MD, DO, NP, or CRNA
Format: Hybrid. Time commitment: 6 weeks.
The listed price is $8,950. Confirm the latest tuition, fees, and payment options with [object Object].
The listing includes a certificate signal. Accreditation note: APA. Confirm credential eligibility directly with the provider before enrolling.
The current listing status is No New Dates. Use the provider website for the latest enrollment status.
By CIIS
Shares course skills and categories
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Next cohort: Jun 1, 2026
Source lists: Estimated 145 hours
Delivery: Online + San Francisco, United States + Portland, United States
Includes medicine self-experience
By PRATI
Shares course skills and categories
PRATI’s Ketamine-Assisted Psychotherapy (KAP) Training Program is a comprehensive four-day course designed for mental health and medical professionals who are interested in exploring the transformative potential of psychedelic therapy.
Next cohort: Jul 13, 2026
Self-paced access
Source lists: Estimated 80 hours
Delivery: Self-paced + Online
Includes medicine self-experience
By IPI
Shares course skills and categories
The IPI Online Psychedelic-Assisted Therapy Training is a year-long program designed for therapists, physicians, nurses, and other allied mental healthcare professionals who want to expand their skill set in psychedelic-assisted therapy.
Source lists: 140 hours
Delivery: Online